Abstract :

Background: Leprosy (Hansen’s disease) remains a public health concern in Sri Lanka decades after achieving WHO elimination as a public health problem (<1 prevalence per 10,000) in 1995. Although prevalence targets were reached, new case detection rates have remained persistently elevated, with 1,000–2,000 new cases annually and evidence of ongoing transmission, including among children. Continued disability and social stigma complicate disease control.

Objectives: To evaluate current epidemiology, control efforts, and barriers to elimination in Sri Lanka, and propose an evidence-based way forward, aligned with the WHO “Towards Zero Leprosy” Strategy (2021–2030).

Methods: A mixed-methods approach was used, combining national surveillance data (Ministry of Health and Anti-Leprosy Campaign), active case finding surveys, quality of life and stigma studies, and review of global control strategies. Quantitative data on annual case detection rates by age, disability, and geographic region were compiled. A narrative synthesis of interventions and outcomes was undertaken.

Results: Sri Lanka reports approximately 1,500–2,000 new leprosy cases annually, with about 10% in children. Case detection rates fluctuate between 7 and 12 per 100,000 population. Grade 2 disability proportions (visible deformities) range from 6–8%, indicating delayed diagnosis. Active case finding in endemic districts reveals hidden disease burdens (~20/10,000 in targeted surveys). Stigma and quality-of-life impacts remain substantial. Global strategies emphasize integrated services, enhanced surveillance, and prevention of transmission, stigma reduction, and disability management.

Conclusions: While past efforts successfully reduced prevalent leprosy, sustained transmission persists. Achieving elimination of transmission and zero disability requires strengthened surveillance, integrated health services, intensified contact tracing with post-exposure prophylaxis (PEP), stigma reduction programs, and regionally tailored interventions. A roadmap toward elimination by 2035 is proposed, aligning national targets with WHO guidance.

---

Keywords :

Leprosy Elimination in Sri Lanka

---

References :

1. Lockwood DNJ, Suneetha S. Leprosy: too complex a disease for a simple elimination paradigm. Bull World Health Organ. 2005;83(3):230–5.
   Available from: https://www.who.int/bulletin/volumes/83/3/230.pdf
2. World Health Organization. Towards zero leprosy: Global leprosy (Hansen’s disease) strategy 2021–2030. Geneva: WHO; 2021. Available from: https://www.who.int/publications/i/item/9789290228509
3. Ministry of Health Sri Lanka. National Strategic Plan for Leprosy Elimination 2021–2025. Colombo: Epidemiology Unit, Ministry of Health; 2021.Available from: https://www.epid.gov.lk/web/images/pdf/Leprosy/strategic_plan_leprosy_2021_2025.pdf

4. Nicholls PG, Croft RP, Richardus JH, Smith WCS. Delay in presentation, an indicator for nerve function impairment in leprosy. Lepr Rev. 2003;74(4):386–97. Available from: https://leprosyreview.org/article/74/4/386
5. Saunderson P, Richardus JH. Challenges for leprosy control after elimination. Lepr Rev. 2013;84(1):1–6.
   Available from: https://leprosyreview.org/article/84/1/1
6. World Health Organization. Global leprosy update, 2022: towards zero leprosy. Wkly Epidemiol Rec. 2023;98(35):429–52.
   Available from: https://www.who.int/publications/i/item/who-wer9835-429-452
7. Liyanage, N. R., Arnold, M., & Wijesinghe, M. S. D. (2021). Quality of life among leprosy patients in the western province, Sri Lanka. International Journal Of Community Medicine And Public Health, 8(6), 2665. https://doi.org/10.18203/2394-6040.ijcmph20211967
8. World Health Organization. Global leprosy update, 2023: towards zero leprosy. Wkly Epidemiol Rec. 2024;99(35):421–40. Available from: https://www.who.int/publications/i/item/who-wer9935-421-440
9. Richardus JH, Tiwari A, Barth-Jaeggi T, Arif MA, Banstola NL, Baskota R, et al. Leprosy elimination needs to be sustained: challenges and opportunities. PLoS Negl Trop Dis. 2020;14(9):e0008659. Available from: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008659
10. Smith WCS, Aerts A. Role of contact tracing and early detection in leprosy control. Lepr Rev. 2014;85(1):2–17.
    Available from: https://leprosyreview.org/article/85/1/2
11. World Health Organization Expert Committee on Leprosy. Eighth report. Geneva: WHO; 2012.
    Available from: https://apps.who.int/iris/handle/10665/75151
12. De Silva NL, Illangasinghe S, Senaratne A, Karunaratne K. Hidden leprosy prevalence detected through active case finding in an urban Sri Lankan setting. Lepr Rev. 2019;90(3):315–23. Available from: https://leprosyreview.org/article/90/3/315
13. Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel WH, Richardus JH. Leprosy post-exposure prophylaxis: systematic review and meta-analysis. PLoS Med. 2016;13(3):e1001961. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001961
14. Wijesinghe SD, Galappaththy GN, Karunaratne K, Pathirana KD. Quality of life among patients with leprosy in Western Province, Sri Lanka. Int J Dermatol. 2018;57(7):803–9. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ijd.14019
15. van Brakel WH, Sunkari VG, Lobo D, Virmond M, Peters RMH, et al. Stigma and mental health among people affected by leprosy: a systematic review. PLoS Negl Trop Dis. 2012;6(2):e1586. Available from: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001586